Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s disease, a post hoc analysis

BACKGROUND: Matrix metalloproteinase-9 (MMP-9) is a novel marker of intestinal inflammation. The aim of this study was to assess if serum MMP-9 levels predict clinical flare in patients with quiescent Crohn’s disease (CD). METHODS: This study was a post hoc analysis of a prospective observational st...

Descripción completa

Detalles Bibliográficos
Autores principales: Yablecovitch, Doron, Kopylov, Uri, Lahat, Adi, Amitai, Michal M., Klang, Eyal, Ben-Ami Shor, Dana, Neuman, Sandra, Levhar, Nina, Fudim, Ella, Avidan, Benjamin, Laish, Ido, Selinger, Limor, Zingboim-Orbach, Noam, Picard, Orit, Yavzori, Miri, Eliakim, Rami, Ben-Horin, Shomron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785911/
https://www.ncbi.nlm.nih.gov/pubmed/31636712
http://dx.doi.org/10.1177/1756284819881590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785911/
https://www.ncbi.nlm.nih.gov/pubmed/31636712
http://dx.doi.org/10.1177/1756284819881590

Ejemplares similares